Drug rebate agreements in open-house procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
No estimated value or volume – potential revenue is unknown and may be low or zero if no prescriptions are filled under...
The notice explicitly states it is not a procurement procedure under EU/German procurement law, so standard remedies (e...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Jun 2027
- Supply of pharmaceutical products for non-exclusive discount agreements under German Social Code (§ 130a Abs. 8 SGB V)
- 35 different active substances and combinations as listed per lot
Show full summary
IKK classic is conducting a non-exclusive open-house procedure under German law (§ 130a Abs. 8 SGB V) for discount agreements on various pharmaceutical active substances. Any qualified pharmaceutical entrepreneur can join on non-negotiable, equal terms. Contracts run from 1 July 2025 to 30 June 2027, with rolling admission until 5 May 2027. The notice uses standard procurement forms but is explicitly not subject to procurement law. No estimated contract value or award criteria are provided.
Risks
No estimated value or volume – potential revenue is unknown and may be low or zero if no prescriptions are filled under...
The notice explicitly states it is not a procurement procedure under EU/German procurement law, so standard remedies (e...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG (or a consortium of such)
- Accept non-negotiable discount terms set by IKK classic
Administrative
- Submit signed contract and all required documents (self-declarations, trade register extract)
Buyer
Lots (35)
LOT-0001
Adalimumab (excluding 80 mg); ATC: L04AB04
Supply of Adalimumab (excluding 80 mg dosage form) under a non-exclusive discount agreement. Contract period: July 2025 – June 2027.
Location
Duration
Category
Deadline
Award details
Adalimumab
ohne 80 mg
ATC-Code: L04AB04
Value note
Show original TED data
Original lot title
Adalimumab; ohne 80 mg; ATC-Code: L04AB04
Original TED description
Adalimumab; ohne 80 mg; ATC-Code: L04AB04
LOT-0002
Adalimumab (80 mg); ATC: L04AB04
Supply of Adalimumab 80 mg under a non-exclusive discount agreement. Contract period: July 2025 – June 2027.
Location
Duration
Category
Deadline
Award details
Adalimumab
80 mg
ATC-Code: L04AB04
Value note
Show original TED data
Original lot title
Adalimumab; 80 mg; ATC-Code: L04AB04
Original TED description
Adalimumab; 80 mg; ATC-Code: L04AB04
LOT-0003
Atovaquone and Proguanil; ATC: P01BB51
Supply of Atovaquone and Proguanil combination under a non-exclusive discount agreement. Contract period: July 2025 – June 2027.
Location
Duration
Category
Deadline
Award details
Atovaquon und Proguanil
ATC-Code: P01BB51
Value note
Show original TED data
Original lot title
Atovaquon und Proguanil; ATC-Code: P01BB51
Original TED description
Atovaquon und Proguanil; ATC-Code: P01BB51
LOT-0004
Betamethason; ATC-Code: H02AB01
Betamethason; ATC-Code: H02AB01
Location
Duration
Category
Award details
Betamethason
ATC-Code: H02AB01
LOT-0005
Cefixim; Filmtabletten; ATC-Code: J01DD08
Cefixim; Filmtabletten; ATC-Code: J01DD08
Location
Duration
Category
Award details
Cefixim
Filmtabletten
ATC-Code: J01DD08
LOT-0006
Ciclesonid; ATC-Code: R03BA08
Ciclesonid; ATC-Code: R03BA08
Location
Duration
Category
Award details
Ciclesonid
ATC-Code: R03BA08
LOT-0007
Cobimetinib; ATC-Code: L01EE02
Cobimetinib; ATC-Code: L01EE02
Location
Duration
Category
Award details
Cobimetinib
ATC-Code: L01EE02
LOT-0008
Codein und Paracetamol; ATC-Code: N02AJ06
Codein und Paracetamol; ATC-Code: N02AJ06
Location
Duration
Category
Award details
Codein und Paracetamol
ATC-Code: N02AJ06
LOT-0009
Darifenacin; ATC-Code: G04BD10
Darifenacin; ATC-Code: G04BD10
Location
Duration
Category
Award details
Darifenacin
ATC-Code: G04BD10
LOT-0010
Denosumab; 60 mg; ATC-Code: M05BX04
Denosumab; 60 mg; ATC-Code: M05BX04
Location
Duration
Category
Award details
Denosumab
60 mg
ATC-Code: M05BX04
LOT-0011
Denosumab; 120 mg; Durchstechflaschen; ATC-Code: M05BX04
Denosumab; 120 mg; Durchstechflaschen; ATC-Code: M05BX04
Location
Duration
Category
Award details
Denosumab
120 mg
Durchstechflaschen
ATC-Code: M05BX04
LOT-0012
Denosumab; 120 mg; Fertigspritzen; ATC-Code: M05BX04
Denosumab; 120 mg; Fertigspritzen; ATC-Code: M05BX04
Location
Duration
Category
Award details
Denosumab
120 mg
Fertigspritzen
ATC-Code: M05BX04
LOT-0013
Doxylamin und Pyridoxin; ATC-Code: R06AA59
Doxylamin und Pyridoxin; ATC-Code: R06AA59
Location
Duration
Category
Award details
Doxylamin und Pyridoxin
ATC-Code: R06AA59
LOT-0014
Elektrolytlösungen; ATC-Code: B05XA
Elektrolytlösungen; ATC-Code: B05XA
Location
Duration
Category
Award details
Elektrolytlösungen
ATC-Code: B05XA
LOT-0015
Empagliflozin; ATC-Code: A10BK03
Empagliflozin; ATC-Code: A10BK03
Location
Duration
Category
Award details
Empagliflozin
ATC-Code: A10BK03
LOT-0016
Estradiol; Pflaster transdermal; ATC-Code: G03CA03
Estradiol; Pflaster transdermal; ATC-Code: G03CA03
Location
Duration
Category
Award details
Estradiol
Pflaster transdermal
ATC-Code: G03CA03
LOT-0017
Felbamat; ATC-Code: N03AX10
Felbamat; ATC-Code: N03AX10
Location
Duration
Category
Award details
Felbamat
ATC-Code: N03AX10
LOT-0018
Fluorouracil; Creme; ATC-Code: D11AF05 (ADV); L01BC02 (WHO)
Fluorouracil; Creme; ATC-Code: D11AF05 (ADV); L01BC02 (WHO
Location
Duration
Category
Award details
Fluorouracil
Creme
ATC-Code: D11AF05 (ADV)
L01BC02 (WHO
LOT-0019
Follitropin alfa; ATC-Code: G03GA05
Follitropin alfa; ATC-Code: G03GA05
Location
Duration
Category
Award details
Follitropin alfa
ATC-Code: G03GA05
LOT-0020
Follitropin beta; ATC-Code: G03GA06
Follitropin beta; ATC-Code: G03GA06
Location
Duration
Category
Award details
Follitropin beta
ATC-Code: G03GA06
LOT-0021
Glucagon; ATC-Code: H04AA01
Glucagon; ATC-Code: H04AA01
Location
Duration
Category
Award details
Glucagon
ATC-Code: H04AA01
LOT-0022
Goserelin; ATC-Code: L02AE03
Goserelin; ATC-Code: L02AE03
Location
Duration
Category
Award details
Goserelin
ATC-Code: L02AE03
LOT-0023
Isosorbidmononitrat; ATC-Code: C01DA14
Isosorbidmononitrat; ATC-Code: C01DA14
Location
Duration
Category
Award details
Isosorbidmononitrat
ATC-Code: C01DA14
LOT-0024
Lapatinib; ATC-Code: L01EH01
Lapatinib; ATC-Code: L01EH01
Location
Duration
Category
Award details
Lapatinib
ATC-Code: L01EH01
LOT-0025
Leuprorelin; ATC-Code: L02AE02
Leuprorelin; ATC-Code: L02AE02
Location
Duration
Category
Award details
Leuprorelin
ATC-Code: L02AE02
LOT-0026
Mesalazin; ohne Suppositorien; ohne Tabletten magensaftresistent 500 mg; ATC-Code: A07EC02
Mesalazin; ohne Suppositorien; ohne Tabletten magensaftresistent 500 mg; ATC-Code: A07EC02
Location
Duration
Category
Award details
Mesalazin
ohne Suppositorien
ohne Tabletten magensaftresistent 500 mg
ATC-Code: A07EC02
LOT-0027
Mycophenolsäure; Wirkstärke 1 g; ATC-Code: L04AA06
Mycophenolsäure; Wirkstärke 1 g; ATC-Code: L04AA06
Location
Duration
Category
Award details
Mycophenolsäure
Wirkstärke 1 g
ATC-Code: L04AA06
LOT-0028
Peginterferon alfa-2a; ATC-Code: L03AB11
Peginterferon alfa-2a; ATC-Code: L03AB11
Location
Duration
Category
Award details
Peginterferon alfa-2a
ATC-Code: L03AB11
LOT-0029
Polystyrolsulfonat; ATC-Code: V03AE01
Polystyrolsulfonat; ATC-Code: V03AE01
Location
Duration
Category
Award details
Polystyrolsulfonat
ATC-Code: V03AE01
LOT-0030
Sarilumab; ATC-Code: L04AC14
Sarilumab; ATC-Code: L04AC14
Location
Duration
Category
Award details
Sarilumab
ATC-Code: L04AC14
LOT-0031
Sulfamethoxazol und Trimethoprim; ATC-Code: J01EE01
Sulfamethoxazol und Trimethoprim; ATC-Code: J01EE01
Location
Duration
Category
Award details
Sulfamethoxazol und Trimethoprim
ATC-Code: J01EE01
LOT-0032
Tapentadol; Filmtabletten; ATC-Code: N02AX06
Tapentadol; Filmtabletten; ATC-Code: N02AX06
Location
Duration
Category
Award details
Tapentadol
Filmtabletten
ATC-Code: N02AX06
LOT-0033
Tranylcypromin; ATC-Code: N06AF04
Tranylcypromin; ATC-Code: N06AF04
Location
Duration
Category
Award details
Tranylcypromin
ATC-Code: N06AF04
LOT-0034
Umeclidinium; ATC-Code: R03BB07
Umeclidinium; ATC-Code: R03BB07
Location
Duration
Category
Award details
Umeclidinium
ATC-Code: R03BB07
LOT-0035
Zuclopenthixol; ATC-Code: N05AF05
Zuclopenthixol; ATC-Code: N05AF05
Location
Duration
Category
Award details
Zuclopenthixol
ATC-Code: N05AF05
Procurement Details
- Publication date
- 18 May 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 319823-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
No estimated value or volume – potential revenue is unknown and may be low or zero if no prescriptions are filled under...
The notice explicitly states it is not a procurement procedure under EU/German procurement law, so standard remedies (e...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications